Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES

  • Read more about 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES
Patent Cooperation Treaty
PCT/US1997/016718
Filed on 1997-09-19

PRODUCTION OF ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES

  • Read more about PRODUCTION OF ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
Patent Cooperation Treaty
PCT/US2000/008802
Filed on 2000-03-31

CC CHEMOKINE RECEPTOR 5, ANTIBODIES THERETO, TRANSGENIC ANIMALS

  • Read more about CC CHEMOKINE RECEPTOR 5, ANTIBODIES THERETO, TRANSGENIC ANIMALS
Patent Cooperation Treaty
PCT/US1997/009586
Filed on 1997-05-28

CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, PFS230

  • Read more about CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, PFS230
US Patent 6,316,000
Filed on 1997-10-20

IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY

  • Read more about IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY
US Patent 6,190,656
Filed on 1997-09-02

REGULATION OF T CELL EFFECTOR ACTIVITY BY T CELL RECEPTOR LIGANDS WITH INCOMPLETE AGONIST (MIXED AGONIST-ANTAGONIST) PROPERTIES

  • Read more about REGULATION OF T CELL EFFECTOR ACTIVITY BY T CELL RECEPTOR LIGANDS WITH INCOMPLETE AGONIST (MIXED AGONIST-ANTAGONIST) PROPERTIES
US Application 08/931,192
Filed on 1997-09-15

DETERMINING THE ABILITY OF A COMPOUND TO INHIBIT THE CYCLOPROPANATION OF MYCOLIC ACIDS IN PATHOGENIC MYCOBACTERIA

  • Read more about DETERMINING THE ABILITY OF A COMPOUND TO INHIBIT THE CYCLOPROPANATION OF MYCOLIC ACIDS IN PATHOGENIC MYCOBACTERIA
US Application 08/773,639
Filed on 1996-06-18

PFS25-28 FUSION AS A MALARIA TRANSMISSION BLOCKING VACCINE

  • Read more about PFS25-28 FUSION AS A MALARIA TRANSMISSION BLOCKING VACCINE
Patent Cooperation Treaty
PCT/US1997/017666
Filed on 1997-09-29

HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS

  • Read more about HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS
US Patent 6,685,942
Filed on 1997-08-26

Method of Decreasing Radiation or Radio-Mimetic Chemotherapy for Hematopoietic Pluripotent Cell Engraftment

  • Read more about Method of Decreasing Radiation or Radio-Mimetic Chemotherapy for Hematopoietic Pluripotent Cell Engraftment
US Patent 6,103,694
Filed on 1998-04-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 556
  • Page 557
  • Page 558
  • Page 559
  • Page 560
  • Page 561
  • Page 562
  • Page 563
  • Page 564
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health